BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 8799913)

  • 1. Leuprolide acetate for treating refractory or persistent ovarian granulosa cell tumor.
    Fishman A; Kudelka AP; Tresukosol D; Edwards CL; Freedman RS; Kaplan AL; Girtanner RE; Kavanagh JJ
    J Reprod Med; 1996 Jun; 41(6):393-6. PubMed ID: 8799913
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical outcomes of leuprolide acetate in the treatment of recurrent ovarian granulosa cell tumors.
    Foster KI; Flores Legarreta A; Kamat R; Handley KF; Glassman D; How JA; Lawson BC; Westin SN; Ramondetta LM; Frumovitz M; Gershenson DM; Sood AK; Hillman RT
    Am J Obstet Gynecol; 2023 Jun; 228(6):724.e1-724.e9. PubMed ID: 36907533
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complete response in a patient with granulosa cell tumor treated with a combination of leuprolide and tamoxifen.
    Keskin S; Bengisu E; Tuzlali S; Aydiner A
    Onkologie; 2012; 35(7-8):451-3. PubMed ID: 22846979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anastrozole therapy in recurrent ovarian adult granulosa cell tumors: a report of 2 cases.
    Freeman SA; Modesitt SC
    Gynecol Oncol; 2006 Nov; 103(2):755-8. PubMed ID: 16870240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of response to hormone therapy in patients with measurable adult granulosa cell tumors of the ovary.
    van Meurs HS; van der Velden J; Buist MR; van Driel WJ; Kenter GG; van Lonkhuijzen LR
    Acta Obstet Gynecol Scand; 2015 Nov; 94(11):1269-75. PubMed ID: 26230362
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GnRH agonist therapy in a patient with recurrent ovarian granulosa cell tumors.
    Kim HJ; Lee SC; Bae SB; Kwon KW; Kim CK; Lee NS; Lee KT; Won JH; Hong DS; Park HS
    J Korean Med Sci; 2009 Jun; 24(3):535-8. PubMed ID: 19543423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A phase II study of leuprolide in advanced/recurrent endometrial cancer.
    Covens A; Thomas G; Shaw P; Ackerman I; Osborne R; Lukka H; Carey M; Franssen E; Roche K
    Gynecol Oncol; 1997 Jan; 64(1):126-9. PubMed ID: 8995560
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leuprolide acetate as a salvage-therapy in relapsed epithelial ovarian cancer.
    Marinaccio M; D'Addario V; Serratì A; Pinto V; Cagnazzo G
    Eur J Gynaecol Oncol; 1996; 17(4):286-8. PubMed ID: 8856307
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hormonal treatment of a recurrent granulosa cell tumor of the ovary: case report and review of the literature.
    Hardy RD; Bell JG; Nicely CJ; Reid GC
    Gynecol Oncol; 2005 Mar; 96(3):865-9. PubMed ID: 15721440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness, pharmacokinetics, and safety of a new sustained-release leuprolide acetate 3.75-mg depot formulation for testosterone suppression in patients with prostate cancer: a Phase III, open-label, international multicenter study.
    Marberger M; Kaisary AV; Shore ND; Karlin GS; Savulsky C; Mis R; Leuratti C; Germa JR
    Clin Ther; 2010 Apr; 32(4):744-57. PubMed ID: 20435244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapy of advanced ovarian juvenile granulosa cell tumors.
    Schneider DT; Calaminus G; Wessalowski R; Pathmanathan R; Harms D; Göbel U
    Klin Padiatr; 2002; 214(4):173-8. PubMed ID: 12165898
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hormonal Therapy in Pretreated Patients With Recurrent Ovary Granulosa Cell Tumor.
    Dogan I; Aydin E; Topuz S; Saip P; Salihoglu MY; Aydiner A
    J Pharm Pract; 2024 Feb; 37(1):146-150. PubMed ID: 36148892
    [No Abstract]   [Full Text] [Related]  

  • 13. Leuprolide acetate in advanced ovarian serous tumor of low malignant potential. A case report.
    Tresukosol D; Kudelka AP; Edwards CL; Silva EG; Kanojia M; Kavanagh JJ
    J Reprod Med; 1996 May; 41(5):363-6. PubMed ID: 8725765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bleomycin, etoposide, and cisplatin combination therapy of ovarian granulosa cell tumors and other stromal malignancies: A Gynecologic Oncology Group study.
    Homesley HD; Bundy BN; Hurteau JA; Roth LM
    Gynecol Oncol; 1999 Feb; 72(2):131-7. PubMed ID: 10021290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Third-line chemotherapy with tyrosine kinase inhibitor (imatinib mesylate) in recurrent ovarian granulosa cell tumor: case report.
    Raspagliesi F; Martinelli F; Grijuela B; Guadalupi V
    J Obstet Gynaecol Res; 2011 Dec; 37(12):1864-7. PubMed ID: 21955167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A phase 2 study of anastrozole in patients with oestrogen receptor and/progesterone receptor positive recurrent/metastatic granulosa cell tumours/sex-cord stromal tumours of the ovary: The PARAGON/ANZGOG 0903 trial.
    Banerjee SN; Tang M; O'Connell RL; Sjoquist K; Clamp AR; Millan D; Nottley S; Lord R; Mullassery VM; Hall M; Gourley C; Bonaventura T; Goh JC; Sykes P; Grant PT; McNally O; Alexander L; Kelly C; Carty K; Divers L; Bradshaw N; Edmondson RJ; Friedlander M;
    Gynecol Oncol; 2021 Oct; 163(1):72-78. PubMed ID: 34412908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcome of patients with recurrent adult-type granulosa cell tumors--a Taiwanese Gynecologic Oncology Group study.
    Wang PH; Sun HD; Lin H; Wang KL; Liou WS; Hung YC; Chiang YC; Lu CH; Lai HC; Chang TC;
    Taiwan J Obstet Gynecol; 2015 Jun; 54(3):253-9. PubMed ID: 26166336
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of poor-prognosis sex cord-stromal tumors of the ovary with the combination of bleomycin, etoposide, and cisplatin.
    Gershenson DM; Morris M; Burke TW; Levenback C; Matthews CM; Wharton JT
    Obstet Gynecol; 1996 Apr; 87(4):527-31. PubMed ID: 8602303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aromatase inhibitors--a viable option for recurrent granulosa cell tumour of ovary: overview and case report.
    Abdul Munem A; Al-Bahrani B; Mehdi I; Kamona A; Nadas AM
    J Pak Med Assoc; 2012 May; 62(5):505-7. PubMed ID: 22755322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Recurrent and 2nd line therapy in ovarian carcinoma: an overview of conventional systemic therapy modalities].
    du Bois A; Lück HJ; Meerpohl HG
    Zentralbl Gynakol; 1997; 119(7):299-323. PubMed ID: 9340970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.